Correct higher order structure (HOS) is critical to ensure biopharmaceutical products' proper functionality, activity, and stability. The ICH Q6B guideline for testing procedures and acceptance criteria for biologics states that HOS characterization is a key component in defining critical quality attributes (CQAs) for proteins or peptides. As experts in therapeutic proteins and peptides, CD Formulation uses a variety of analytical techniques, including mass spectrometry, chromatography, spectroscopy, and more, to fully evaluate the higher-order structure of proteins and peptides, paving the way for your next steps.
Changes in HOS can affect the quality, stability, safety, and efficacy of protein or peptide biopharmaceutical products and increase the potential for immunogenicity and loss of biological function. Therefore, such analyses are needed to measure and monitor secondary, tertiary, and quaternary structures during early and late characterization and as part of comparability studies. Therefore, such analyses are needed to measure and monitor secondary, tertiary, and quaternary structures during formulation development and process manufacturing, which is also part of comparability studies.
Fig.1 Protein higher-order structures (HOS). (CD Formulation)
At CD Formulation, our experienced protein scientists can apply a variety of analytical methods to obtain high-level structural data about proteins and peptides, which can guide subsequent formulation development, process development, stability studies, etc. Our extensive high-level structural characterization services include:
Protein or peptide secondary structure refers to the specific conformation formed by the backbone atoms of the polypeptide chain circling or folding along a certain axis, that is, the spatial arrangement of backbone atoms of the peptide chain, without involving the side chains of amino acid residues. α-helix and β-fold are the main forms of secondary structure.
Characterization Technologies: Circular dichroism (CD) spectroscopy, fourier transform infrared (FTIR) spectroscopy.
Fig.2 Protein secondary structure. (CD Formulation)
The tertiary structure refers to the relative spatial position of all amino acid residues in a single polypeptide chain, that is, the three-dimensional spatial structure of the entire peptide chain, which usually includes α helix, β sheet, random coil, and loop. The formation and stability of the tertiary structure depend on the hydrophobic bonds, salt bonds, disulfide bonds, hydrogen bonds, etc. between the amino acid side chains.
Fig.3 Protein tertiary structure. (CD Formulation)
Characterization Technologies: X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy or cryo-electron microscopy (cryo-EM), hydrogen-deuterium exchange (HDX)-MS.
The quaternary structure refers to a more complex protein complex with a complete structure formed by the interaction of multiple polypeptide chains. It mainly describes the spatial arrangement of protein subunits and the connection and interaction between subunits and doesn't involve the internal structure of subunits. The formation and stability of the quaternary structure are similar to the tertiary structure and are mainly formed by hydrophobic interaction, hydrogen bonding, ionic bonding, etc.
Fig.4 Protein quaternary structure. (CD Formulation)
Characterization Technologies: Similar to tertiary structural characterization, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy or cryo-electron microscopy (cryo-EM), and hydrogen-deuterium exchange (HDX)-MS.
As part of biosimilarity study, protein or peptide biosimilar HOS data is one of the key information to demonstrate its similarity and equivalence to the reference product. These data include the amino acid sequence, three-dimensional structure, secondary structure, and possible post-translational modifications of the drug. Regulatory agencies require that protein or peptide biosimilar development must provide these data to ensure that the generic drugs they produce are structurally similar to the original reference product and do not have major differences related to efficacy or safety.
Our protein expert team provides protein or peptide biosimilar HOS analysis services, combining multiple methods with expert data interpretation to facilitate the evaluation of comparative analytical characterization data of multiple batches of biosimilars and reference products to assess the variability of quality attributes.
A comprehensive HOS characterization method panel is an important part of the intact protein or peptide product characterization program. These methods can be used to compare a large number of identical products to ensure batch-to-batch consistency and comparability, as well as establish biosimilarity. Thanks to many years of experience and expertise in protein/peptide characterization, CD Formulation has established several first-class advanced technology platforms. Our pharmaceutical team and protein chemist team often combine multiple protein and peptide characterization strategies, including but not limited to:
Available Analysis Technologies | Technologies | Structure |
Circular dichroism (CD) spectroscopy | The technology is based on the differential absorption of left- and right-handed circularly polarized light by proteins, allowing accurate interrogation of secondary structural elements such as alpha helices and beta sheets. | Secondary |
Fourier transform infrared (FTIR) spectroscopy | The secondary structure is discerned by measuring the absorption of infrared light by proteins or peptides, providing comprehensive structural details on alpha helices, beta sheets, and other secondary structural features such as random coils. | Secondary |
X-ray crystallography | It is used to elucidate the three-dimensional structure of proteins at atomic resolution. The technology involves the growth of high-quality protein crystals, which are then examined with a battery of X-rays. The diffraction pattern produced by X-ray scattering provides a complex description of the spatial arrangement of atoms within the protein molecule. | Tertiary and quaternary |
Nuclear magnetic resonance (NMR) spectroscopy | It is used to determine protein structure in solution. Comprehensive data on atomic distances and relative atomic directions can be obtained by detecting the spin state of the nuclei in the protein under the influence of an external magnetic field, which helps to accurately determine the protein structure. | Tertiary and quaternary |
Cryo-electron microscopy (cryo-EM) | We perform protein aggregation studies using dynamic light scattering, multi-angle laser light scattering (MALS), and sedimentation velocity analytical ultracentrifugation (SV-AUC). | Tertiary and quaternary |
Hydrogen-deuterium exchange (HDX)-MS | Combined with other HOS characterization techniques to obtain important information about protein conformation, dynamics, and folding. | Tertiary and quaternary |
Small-angle X-ray scattering (SAXS) | It is used to determine protein structure in solution, providing key insights into shape, size, and conformation, and a comprehensive overview of a protein's higher-order structure. | Primary, Secondary, Tertiary and quaternary |
BioInformatics | It is used to analyze primary amino acid sequences and predict secondary and tertiary protein structures, including:
|
Primary, Secondary, Tertiary and quaternary |
Published Data
Technology: Circular Dichroism Spectral for Detection of Subtle Higher Order Structural Changes in Therapeutic Protein
Journal: J Pharm Sci.
IF: 4.6
Published: 2018
Results:
Circular dichroism (CD) spectroscopy is a widely used technique for measuring protein HOS, but it remains difficult to assess HOS with a high degree of accuracy and precision. The authors successfully develop a simple method to enhance the precision of the CD spectral measurements through normalization of the CD spectra by the protein concentration determined directly from the CD measurement. The result show that this method can be implemented to successfully detect small CD spectral changes in multiple forced degradation studies as well as comparability assessments during biologics drug development.
The ultimate goal of CD Formulation is to provide innovative protein or peptide HOS characterization solutions for the biopharmaceutical industry using advanced analytical techniques. We always work closely with our customers to provide customized solutions based on their needs and project goals, ensuring the accuracy and reliability of the results. Please feel free to contact us if you are interested in our services. We will provide you with the most professional advice and support to ensure the smooth launch and implementation of your project.
References